Decitabine Alone or in Combination With Venetoclax, Gilteritinib, Enasidenib, or Ivosidenib as Maintenance Therapy for the Treatment of Acute Myeloid Leukemia in Remission
Clinical trial NCT05010772 · RECRUITING
Trial details
- NCT number
- NCT05010772
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-25
- Primary completion
- 2026-12-31
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.